Skip to main content
Skip to recall details
Verified · FDAClass III — Low RiskMedications

Buprenorphine Sublingual Tablets , 2 mg, 30 Tablets , Rx only Recall 2026

BUPRENORPHINEIssued August 19, 2026Updated Reviewed by the Recall Watch editorial team

BUPRENORPHINE Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481- — recalled per FDA on 8/19/2026. Reason: Labeling: Label Mix-up.

Agency
FDA
Issued
Aug 19, 2026
Brand
BUPRENORPHINE
Distribution
1 states
Lots affected
2
What to do right now

Steps to take for this recall

  1. Stop using it

    Take it out of rotation. Don't consume, wear, or operate.

  2. Verify the match

    Compare lot numbers, UPCs, and dates against your product.

  3. Return or dispose

    Follow the manufacturer's instructions to refund or safely dispose.

Free case review

Were you or someone in your household prescribed this medication?

  • Free
  • No obligation
  • Licensed attorneys
Attorney advertising.Details

Recall Watch is not a law firm and does not provide legal or medical advice. Free case reviews are provided by independent licensed attorneys; Recall Watch may receive a referral fee. Prior results do not guarantee a similar outcome. Submitting this form does not create an attorney-client relationship. See our terms and privacy policy.

Verified summary of the official U.S. Food and Drug Administration notice · Issued August 19, 2026 · Last synced Nov 1, 2026

What's recalled

Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).

Available at AmazonAd
White first-aid box with bandages

Restock your medicine cabinet

First-aid kits, thermometers and OTC basics, searched on Amazon.

Shop at Amazon.com

Need it delivered? Start a free Amazon Prime trial.

Why it was recalled

Labeling: Label Mix-up

Affected products & lot numbers
2 lots called out

Affected Lot Numbers

Check your product label — do not use if your lot number appears below.

Lot Number
Lot # 1030023
Exp Date: 06/30/2027.
Where was it sold
1 state

US Nationwide.

nationwide
Official noticefda.gov
More recalls like this
4 related — by brand, contaminant, and category

Frequently asked questions

Is the BUPRENORPHINE recall still active?

Yes, this recall is currently active as of August 19, 2026. Do not use or consume the affected product.

What lot numbers are affected?

Affected lot numbers: Lot # 1030023, Exp Date: 06/30/2027.. Check the label on your product.

What should I do if I have the recalled BUPRENORPHINE?

Do not consume or use this product. Return it to the store for a full refund, or dispose of it safely.